These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5161 related articles for article (PubMed ID: 5514625)

  • 21. [Photosensitization with DTIC therapy in metastatic malignant melanoma].
    Bolling R; Meyer-Hamme S; Schauder S
    Hautarzt; 1980 Nov; 31(11):602-5. PubMed ID: 7451142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanoma.
    Moore GE; Gerner RE
    Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
    Vorobiof DA; Sarli R; Falkson G
    Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.
    Bedikian AY; Johnson MM; Warneke CL; Papadopoulos NE; Kim K; Hwu WJ; McIntyre S; Hwu P
    Cancer Invest; 2008 Jul; 26(6):624-33. PubMed ID: 18584354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of malignant melanoma with camptothecin (NSC-100880).
    Gottlieb JA; Luce JK
    Cancer Chemother Rep; 1972 Feb; 56(1):103-5. PubMed ID: 5030802
    [No Abstract]   [Full Text] [Related]  

  • 26. Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Cowan DH; Bergsagel DE
    Cancer Chemother Rep; 1971 Apr; 55(2):175-81. PubMed ID: 5118686
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma.
    Hart JS; Ho DH; George SL; Salem P; Gottlieb JA; Frei E
    Cancer Res; 1972 Dec; 32(12):2711-6. PubMed ID: 4644204
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical activity of celecoxib in metastatic malignant melanoma.
    Wilson KS
    Cancer Invest; 2006 Dec; 24(8):740-6. PubMed ID: 17162556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
    Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA
    Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II evaluation of L-alanosine (NSC-153353) for patients with disseminated malignant melanoma.
    Creagan ET; Long HJ; Ahmann DL; Green SJ
    Am J Clin Oncol; 1984 Oct; 7(5):543-4. PubMed ID: 6507375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapy.
    Fregni G; Perier A; Pittari G; Jacobelli S; Sastre X; Gervois N; Allard M; Bercovici N; Avril MF; Caignard A
    Clin Cancer Res; 2011 May; 17(9):2628-37. PubMed ID: 21224372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procarbazine, vincristine, CCNU, and cyclophosphamide (POCC) in the treatment of metastatic malignant melanoma.
    Green MR; Dillman RO; Horton C
    Cancer Treat Rep; 1980 Jan; 64(1):139-42. PubMed ID: 7379047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of mitolactol in advanced malignant melanoma.
    Murray N; Silver H; Shah A; Wilson K
    Cancer Treat Rep; 1985 Jun; 69(6):723-4. PubMed ID: 4016778
    [No Abstract]   [Full Text] [Related]  

  • 34. [Massive-dose cytostatic therapy of malignant skin neoplasms and of malignant neoplasms with skin metastases].
    Denk R; Gebhardt R
    Arch Dermatol Forsch; 1972; 244():418. PubMed ID: 4648735
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II trial of tamoxifen in malignant melanoma.
    Leichman CG; Samson MK; Baker LH
    Cancer Treat Rep; 1982 Jun; 66(6):1447. PubMed ID: 7083248
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine.
    Berd D; Sato T; Maguire HC; Kairys J; Mastrangelo MJ
    J Clin Oncol; 2004 Feb; 22(3):403-15. PubMed ID: 14691123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of cyclophosphamide in man and animals.
    Brock N; Gross R; Hohorst HJ; Klein HO; Schneider B
    Cancer; 1971 Jun; 27(6):1512-29. PubMed ID: 5088222
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
    Carmo-Pereira J; Oliveira Costa F; Pimentel P
    Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of a malignant melanoma with surprisingly radio-sensitive skin metastases].
    Schulze R; Gulbin O
    Hautarzt; 1969 Jan; 20(1):333-4. PubMed ID: 5359058
    [No Abstract]   [Full Text] [Related]  

  • 40. High-dose cyclophosphamide (NSC-26271) for the treatment of metastatic testicular neoplasms.
    Buckner CD; Clift RA; Fefer A; Funk DD; Glucksberg H; Neiman PE; Paulsen A; Storb R; Thomas ED
    Cancer Chemother Rep; 1974; 58(5 Pt 1):709-14. PubMed ID: 4609599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 259.